Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/15437
|
| Title: | Impact of urbanization on adherence to anti-osteoporosis medications after restrained reimbursement policy in Taiwan |
| Authors: | Yang, RS;Yang, TH;Fu, SH;Wang, CY;Wu, CH;Hwang, JS |
| Contributors: | National Center for Geriatrics and Welfare Research |
| Abstract: | Objective: To examine the adherence trend of anti-osteoporosis medication (AOM) users after the implementation of BMD criteria by the Bureau of National Health Insurance in Taiwan, with a focus on the impact of urbanization. Methods: Utilizing Taiwan’s National Health Insurance Research Database, this study identified new users of anti-osteoporosis medications, including denosumab, zoledronate, ibandronate, alendronate, raloxifene, and risedronate, as the study population. The cohort entry date was defined as the first prescription date of AOMs, and adherence rates were evaluated within one year of initiation. The yearly adherence was indicated by the medication possession ratio (MPR). The yearly adherence rate was classified into four groups, MPR]75%, 50 * ~ 75%, 25 * ~ 50%, and ~ 25%. The level of urbanization in areas where AOMs were prescribed was categorized as high, moderate, or low based on the criteria defined by Taiwan’s National Health Research Institutes. Results: The study found a significant increase in high adherence (C 75%) to AOMs within the first year after the implementation of the new reimbursement scheme in 2011. High adherence rates rose from 31.8% in 2008 to 41.7% in 2011 and 54.2% in 2018. Conversely, low adherence (\ 25%) decreased from 38.8% in 2008 to 14.6% in 2018. The highest proportion of high adherence was observed in high-urbanization areas, with a twofold increase from 30% in 2008 to 60% in 2018. The proportion of high adherence to AOMs was lowest in the low urbanization area, however, the proportion increased also nearly doubled from 20% in 2008 to 40% in 2018. Conclusion: The 2011 implementation of new reimbursement criteria led to an increase in adherence to AOMs, with the greatest impact seen in high-urbanization areas. |
| Date: | 2023-07-21 |
| Relation: | Aging Clinical and Experimental Research. 2023 Jul 21;35:S242. |
| Link to: | http://dx.doi.org/10.1007/s40520-023-02442-7 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1594-0667&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:001058500202010 |
| Appears in Collections: | [王貞予] 會議論文/會議摘要
|
Files in This Item:
| File |
Size | Format | |
|---|
| ISI001058500202010.pdf | 68Kb | Adobe PDF | 42 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
